New drug hopes to improve leg blood flow in PAD patients
Disease control
Not yet recruiting
This study tests a new drug called etrinabdione in 30 adults with peripheral arterial disease (PAD), a condition where leg arteries narrow, causing pain while walking. Participants take the drug twice daily for 12 months to see if it is safe and if it improves blood flow and walk…
Phase: PHASE2 • Sponsor: VivaCell Biotechnology España • Aim: Disease control
Last updated May 19, 2026 10:15 UTC